Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bosch, E. P.
Right arrow Articles by Cancilla, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bosch, E. P.
Right arrow Articles by Cancilla, P. A.
NEUROLOGY 1981;31:1408
© 1981 American Academy of Neurology

Peripheral neurofibromatosis and peroneal muscular atrophy

E. Peter Bosch, M.D., Martin J. Murphy, M.D. and Pasquale A. Cancilla, M.D.

Departments of Neurology (Drs. Bosch and Murphy) and Pathology (Dr. Cancilla), University of Iowa College of Medicine, Iowa City, IA.

Address correspondence and reprint requests to Dr. Bosch, Department of Neurology, University of Iowa Hospitals and Clinics, Iowa City, IA 52242.

we studied four patients with peripheral neurofibromatosis and a neuropathy that had the clinical characteristics of peroneal muscular atrophy. Nerve conduction velocities were slowed by less than 40% of normal, and electromyography demonstrated denervation. Sural nerve biopsies from two patients, which were macroscopically free of nerve sheath tumors, were studied by recording the compound action potentials in vitro and by morphometry. These studies demonstrated a chronic axonal neuropathy with reactive Schwann cell changes. Peroneal muscular atrophy in association with neurofibromatosis may be due to progressive neuronal degeneration and may represent another, uncommon manifestation of peripheral neurofibromatosis.




This article has been cited by other articles:


Home page
J. Med. Genet.Home page
R E Ferner, R A C Hughes, S M Hall, M Upadhyaya, and M R Johnson
Neurofibromatous neuropathy in neurofibromatosis 1 (NF1)
J. Med. Genet., November 1, 2004; 41(11): 837 - 841.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
A. Drouet, P. Wolkenstein, J.-P. Lefaucheur, S. Pinson, P. Combemale, R. K. Gherardi, P. Brugieres, J. Salama, P. Ehre, P. Decq, et al.
Neurofibromatosis 1-associated neuropathies: a reappraisal
Brain, September 1, 2004; 127(9): 1993 - 2009.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
A. D. Sperfeld, C. Hein, J. M. Schroder, A. C. Ludolph, and C. O. Hanemann
Occurrence and characterization of peripheral nerve involvement in neurofibromatosis type 2
Brain, May 1, 2002; 125(5): 996 - 1004.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1981 by AAN Enterprises, Inc.